sym	trait
AAR2	-
ABHD12	Liver enzyme levels (alkaline phosphatase)
ABHD12	Systemic lupus erythematosus
ABHD16B	-
ACOT8	-
ACSS1	Cognitive performance
ACSS2	-
ACTL10	-
ACTR5	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease
ADA	-
ADAM33	-
ADIG	-
ADNP	Prostate cancer
ADRA1D	Periodontitis (Mean PAL)
ADRA1D	Preeclampsia
ADRA1D	IgG glycosylation
ADRA1D	Age-related nuclear cataracts
ADRA1D	Microalbuminuria
ADRA1D	Facial morphology (factor 20)
ADRA1D	Diisocyanate-induced asthma
ADRA1D	Paneth cell defects in Crohn's disease
ADRA1D	Mononucleosis
ADRM1	-
AHCY	Liver fibrosis severity in HIV/hepatitis C co-infection
ANGPT4	Social communication problems
ANGPT4	Cognitive performance
ANGPT4	Estradiol plasma levels (breast cancer)
ANGPT4	3-hydroxypropylmercapturic acid levels in smokers
ANGPT4	3-hydroxy-1-methylpropylmercapturic acid levels in smokers
ANGPT4	Posterior cortical atrophy and Alzheimer's disease
ANGPT4	Daytime sleep phenotypes
ANKEF1	-
ANKRD60	Height
AP5S1	Heart rate
AP5S1	Resting heart rate
AP5S1	Photic sneeze reflex
AP5S1	Hepcidin levels
AP5S1	Heart rate variability traits (SDNN)
AP5S1	Heart rate variability traits (RMSSD)
APCDD1L	-
APMAP	-
ARFGAP1	-
ARFGEF2	Anger
ARFRP1	-
ARHGAP40	Schizophrenia
ASIP	-
ASXL1	-
ATP5F1E	-
ATP9A	-
ATRN	Height
ATRN	Attention deficit hyperactivity disorder
ATRN	Freckling
ATRN	Protein C levels
ATRN	Cholesterol, total
ATRN	D-dimer levels
ATRN	Anticoagulant levels
ATRN	Hemostatic factors and hematological phenotypes
ATRN	Prothrombin time
ATRN	Ulcerative colitis
ATRN	Spine bone size
ATRN	Migraine - clinic-based
ATRN	Amyotrophic lateral sclerosis (sporadic)
ATRN	Obesity-related traits
ATRN	Infant length
ATRN	Waist-to-hip ratio adjusted for body mass index
ATRN	Developmental dysplasia of the hip
ATRN	Venous thromboembolism
ATRN	Factor VII levels
ATRN	Triglycerides
ATRN	Thrombosis
ATRN	QRS complex (Cornell)
ATRN	Congenital left-sided heart lesions
ATRN	Melanoma
ATRN	Diisocyanate-induced asthma
ATRN	Response to paliperidone in schizophrenia (PANSS score)
ATRN	Response to paliperidone in schizophrenia (Multivariate)
ATRN	Joint mobility (Beighton score)
ATRN	Hip circumference adjusted for BMI
ATRN	QRS interval (sulfonylurea treatment interaction)
ATRN	Hip circumference
ATRN	Total cholesterol levels
ATRN	Waist-to-hip ratio adjusted for BMI in active individuals
ATRN	Blood protein levels
ATRN	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)
ATRN	Reticulocyte fraction of red cells
ATRN	High light scatter reticulocyte count
ATRN	Reticulocyte count
ATRN	Breast cancer
ATRN	Coronary artery disease
ATRN	Lobe attachment (rater-scored or self-reported)
ATRN	Neuroticism
AURKA	-
AVP	-
B4GALT5	Urate levels in obese individuals
BANF2	-
BCAS1	Bipolar disorder and schizophrenia
BCAS1	Resting heart rate
BCAS1	Venous thromboembolism adjusted for sickle cell variant rs77121243-T
BCAS1	Red cell distribution width
BCAS1	Breast cancer
BCAS4	Breast cancer
BCL2L1	Subcortical brain region volumes
BCL2L1	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder
BCL2L1	Plateletcrit
BCL2L1	Platelet count
BCL2L1	Putamen volume
BFSP1	Obstructive sleep apnea trait (apnea hypopnea index)
BHLHE23	-
BIRC7	-
BLCAP	-
BMP2	Obesity-related traits
BMP7	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder
BMP7	Facial morphology (factor 5, width of mouth relative to central midface)
BMP7	Monobrow
BMP7	Nose size
BMP7	Reticulocyte fraction of red cells
BMP7	High light scatter reticulocyte count
BMP7	High light scatter reticulocyte percentage of red cells
BMP7	Reticulocyte count
BPI	Bipolar disorder and schizophrenia
BPI	Hepcidin levels
BPI	Cerebrospinal fluid biomarker levels
BPIFA1	-
BPIFA2	Smooth-surface caries
BPIFA3	-
BPIFB1	-
BPIFB2	-
BPIFB3	-
BPIFB4	-
BPIFB6	-
BTBD3	-
C20orf27	Survival in colon cancer
C20orf27	Mean corpuscular volume
C20orf85	-
C20orf96	Response to tocilizumab in rheumatoid arthritis
C20orf96	White matter integrity
C20orf141	-
C20orf144	-
C20orf173	-
C20orf194	Ulcerative colitis
C20orf194	IFN-related cytopenia
C20orf194	Attention deficit hyperactivity disorder (combined symptoms)
C20orf194	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
C20orf194	Hair color
C20orf194	Smooth-surface caries
C20orf194	Height
C20orf194	Breast cancer
C20orf194	Type 1 diabetes nephropathy
C20orf194	IgG glycosylation
C20orf194	Inflammatory bowel disease
C20orf194	Type 2 diabetes
C20orf194	Stearic acid (18:0) levels
C20orf194	Dysphagia
C20orf194	Cancer
C20orf194	Cancer (pleiotropy)
C20orf194	Loneliness
C20orf194	Subjective well-being
C20orf194	Age at first birth
C20orf194	Post bronchodilator FEV1/FVC ratio
C20orf194	Hip circumference adjusted for BMI
C20orf194	Iron status biomarkers (iron levels)
C20orf194	Iron status biomarkers (transferrin saturation)
C20orf194	Monocyte count
C20orf194	White blood cell count (basophil)
C20orf194	Basophil percentage of white cells
C20orf194	Immature fraction of reticulocytes
C20orf194	Lymphocyte counts
C20orf194	Lymphocyte percentage of white cells
C20orf194	Monocyte percentage of white cells
C20orf194	Basophil percentage of granulocytes
C20orf194	Granulocyte percentage of myeloid white cells
C20orf194	Mean corpuscular hemoglobin
C20orf194	Red blood cell count
C20orf194	Red cell distribution width
C20orf194	High light scatter reticulocyte count
C20orf194	High light scatter reticulocyte percentage of red cells
C20orf194	Mean corpuscular volume
C20orf194	Asthma
C20orf194	Birth weight
C20orf194	Rubella
C20orf196	Hippocampal atrophy
C20orf196	Information processing speed
C20orf196	Pulmonary function decline
C20orf196	Response to fenofibrate (adiponectin levels)
C20orf196	Height
C20orf196	Response to cytadine analogues (cytosine arabinoside)
C20orf196	Obesity-related traits
C20orf196	Emphysema imaging phenotypes
C20orf196	Warfarin maintenance dose
C20orf196	Verbal declarative memory
C20orf196	Systolic blood pressure
C20orf196	Advanced age-related macular degeneration
C20orf196	Positive affect
C20orf196	Facial morphology (factor 1, breadth of lateral portion of upper face)
C20orf196	Cardiovascular risk factors (age interaction)
C20orf196	Hemoglobin concentration
C20orf196	Prudent dietary pattern
C20orf196	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer
C20orf196	Breast cancer
C20orf202	-
C20orf203	Subjective well-being
C20orf203	White blood cell count (basophil)
C20orf203	Basophil percentage of white cells
C20orf203	Basophil percentage of granulocytes
C20orf204	-
CABLES2	Colorectal cancer
CABLES2	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes
CASS4	Alzheimer's disease (late onset)
CASS4	Interleukin-6 levels
CASS4	Plateletcrit
CASS4	Platelet count
CBFA2T2	-
CBLN4	-
CCM2L	Macrophage colony stimulating factor levels
CD40	Rheumatoid arthritis
CD40	Chronic hepatitis B infection
CD93	-
CDC25B	Bipolar disorder
CDC25B	Skin pigmentation
CDH4	Volumetric brain MRI
CDH4	Cerebrospinal T-tau levels
CDH4	Sudden cardiac arrest
CDH4	Longevity
CDH4	&beta;2-Glycoprotein I (&beta;2-GPI) plasma levels
CDH4	Axial length
CDH4	Migraine - clinic-based
CDH4	Bipolar disorder (body mass index interaction)
CDH4	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
CDH4	Trans fatty acid levels
CDH4	Cognitive decline rate in late mild cognitive impairment
CDH4	Educational attainment (years of education)
CDH4	Obstructive sleep apnea trait (average respiratory event duration)
CDH4	Night sleep phenotypes
CDH4	Multiple system atrophy
CDH4	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes
CDH4	Obesity-related traits
CDH22	IgG glycosylation
CDH26	-
CDK5RAP1	Hair color
CDS2	Male infertility
CDS2	Self-reported allergy
CDS2	Amyotrophic lateral sclerosis (sporadic)
CDS2	Tourette's syndrome or obsessive-compulsive disorder
CDS2	Sitting height ratio
CDS2	Asparaginase hypersensitivity in acute lymphoblastic leukemia
CDS2	Nonsyndromic cleft lip with cleft palate
CDS2	Interleukin-6 levels
CDS2	Eosinophil percentage of white cells
CDS2	Sum eosinophil basophil counts
CDS2	Allergic disease (asthma, hay fever or eczema)
CDS2	Lobe attachment (rater-scored or self-reported)
CDS2	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)
CEBPB	-
CENPB	Bone mineral density
CEP250	Height
CFAP61	Immune response to smallpox vaccine (IL-6)
CFAP61	White wine liking
CFAP61	Exploratory eye movement dysfunction in schizophrenia (total eye scanning length)
CFAP61	Stem cell growth factor beta levels
CHD6	Hippocampal atrophy
CHD6	Gastric adenocarcinoma (histologically verified)
CHD6	Verbal declarative memory
CHD6	Immature fraction of reticulocytes
CHD6	Reticulocyte fraction of red cells
CHD6	High light scatter reticulocyte count
CHD6	High light scatter reticulocyte percentage of red cells
CHD6	Reticulocyte count
CHGB	Hypertension
CHGB	Blood pressure
CHGB	Diastolic blood pressure
CHGB	Systolic blood pressure
CHGB	Response to antipsychotic therapy (extrapyramidal side effects)
CHGB	Inflammatory bowel disease
CHGB	Attention function in attention deficit hyperactive disorder
CHGB	Ulcerative colitis
CHGB	Crohn's disease
CHGB	Lymphocyte counts
CHGB	Lymphocyte percentage of white cells
CHGB	Platelet distribution width
CHGB	Coronary artery disease
CHMP4B	Dysphagia
CHRNA4	Nicotine dependence
CHRNA4	Emphysema imaging phenotypes
CHRNA4	Facial morphology (factor 17, height of vermillion upper lip)
CNBD2	Hip circumference adjusted for BMI
COL9A3	-
COL20A1	-
COMMD7	Type 2 diabetes
COX4I2	-
CPNE1	-
CPXM1	-
CRLS1	Lentiform nucleus volume
CRLS1	Type 1 diabetes nephropathy
CRLS1	Metabolite levels (MHPG)
CRLS1	Glucose homeostasis traits
CRLS1	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes
CRNKL1	-
CSE1L	Non-response to citalopram or escitalopram and depression
CSE1L	Subjective well-being
CSE1L	Positive affect
CSE1L	Intelligence
CSE1L	Intelligence (multi-trait analysis)
CSNK2A1	Tonometry
CSNK2A1	Amyotrophic lateral sclerosis
CSNK2A1	Psoriasis
CSNK2A1	Response to treatment for acute lymphoblastic leukemia
CSNK2A1	Attention deficit hyperactivity disorder (time to onset)
CSNK2A1	Male infertility
CSNK2A1	Hemoglobin
CSNK2A1	Calcium levels
CSNK2A1	Attention deficit hyperactivity disorder
CSNK2A1	Bipolar disorder
CSNK2A1	Nephrotic syndrome (acquired)
CSNK2A1	Subcutaneous adipose tissue
CSNK2A1	Polycystic ovary syndrome
CSNK2A1	Molar-incisor hypomineralization
CSNK2A1	Osteoarthritis (hip)
CSNK2A1	Alcohol consumption
CSNK2A1	Narcolepsy with cataplexy
CSNK2A1	Body mass index in non-asthmatics
CSNK2A1	QT interval
CSNK2A1	Self-reported allergy
CSNK2A1	Attention deficit hyperactivity disorder (combined symptoms)
CSNK2A1	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
CSNK2A1	Amyotrophic lateral sclerosis (sporadic)
CSNK2A1	Atrial fibrillation
CSNK2A1	Bipolar disorder (body mass index interaction)
CSNK2A1	Anger
CSNK2A1	Thyroid peroxidase antibody positivity
CSNK2A1	Systemic lupus erythematosus
CSNK2A1	Multiple sclerosis
CSNK2A1	Height
CSNK2A1	Bipolar disorder and schizophrenia
CSNK2A1	Atopic dermatitis
CSNK2A1	IgG glycosylation
CSNK2A1	Obesity
CSNK2A1	Obesity-related traits
CSNK2A1	QT interval (drug interaction)
CSNK2A1	Tourette's syndrome or obsessive-compulsive disorder
CSNK2A1	Prostate cancer
CSNK2A1	Schizophrenia
CSNK2A1	Seasonality
CSNK2A1	Infant length
CSNK2A1	Sitting height ratio
CSNK2A1	Inflammatory bowel disease
CSNK2A1	Palmitic acid (16:0) levels
CSNK2A1	Asparaginase hypersensitivity in acute lymphoblastic leukemia
CSNK2A1	Urate levels in obese individuals
CSNK2A1	Hair morphology
CSNK2A1	Colorectal cancer (oestrogen-progestogen hormone therapy interaction)
CSNK2A1	Longitudinal change in brain amyloid plaque burden
CSNK2A1	Ulcerative colitis
CSNK2A1	Warfarin maintenance dose
CSNK2A1	White matter hyperintensity burden
CSNK2A1	Glomerular filtration rate (creatinine)
CSNK2A1	Inflammatory skin disease
CSNK2A1	Colorectal cancer
CSNK2A1	Body mass index
CSNK2A1	Psoriasis vulgaris
CSNK2A1	Alzheimer disease and age of onset
CSNK2A1	Coronary artery aneurysm in Kawasaki disease
CSNK2A1	Gut microbiota (beta diversity)
CSNK2A1	Gut microbiota (functional units)
CSNK2A1	Bipolar disorder or attention deficit hyperactivity disorder
CSNK2A1	Serum parathyroid hormone levels
CSNK2A1	Glomerular filtration rate
CSNK2A1	Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder
CSNK2A1	Educational attainment (years of education)
CSNK2A1	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)
CSNK2A1	Non-response to citalopram or escitalopram and depression
CSNK2A1	Subjective well-being
CSNK2A1	Life satisfaction
CSNK2A1	Positive affect
CSNK2A1	Depression
CSNK2A1	Night sleep phenotypes
CSNK2A1	Post bronchodilator FEV1
CSNK2A1	Post bronchodilator FEV1/FVC ratio in COPD
CSNK2A1	Type 2 diabetes (age of onset)
CSNK2A1	Facial morphology (factor 23)
CSNK2A1	Nonsyndromic cleft lip with cleft palate
CSNK2A1	Intelligence
CSNK2A1	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)
CSNK2A1	Cerebrospinal fluid AB1-42 levels
CSNK2A1	Stem cell growth factor beta levels
CSNK2A1	Reading disability or specific language impairment (pleiotropy)
CSNK2A1	Multiple myeloma
CSNK2A1	Resting heart rate
CSNK2A1	Venous thromboembolism adjusted for sickle cell variant rs77121243-T
CSNK2A1	Waist-hip ratio
CSNK2A1	Waist circumference
CSNK2A1	Diastolic blood pressure
CSNK2A1	Interleukin-6 levels
CSNK2A1	Testicular germ cell tumor
CSNK2A1	Monocyte count
CSNK2A1	Immature fraction of reticulocytes
CSNK2A1	Vitamin D levels
CSNK2A1	Eosinophil percentage of white cells
CSNK2A1	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)
CSNK2A1	Waist circumference adjusted for BMI in non-smokers
CSNK2A1	BMI (adjusted for smoking behaviour)
CSNK2A1	Body mass index (joint analysis main effects and smoking interaction)
CSNK2A1	Lymphocyte counts
CSNK2A1	Monocyte percentage of white cells
CSNK2A1	Sum eosinophil basophil counts
CSNK2A1	Waist circumference adjusted for BMI (adjusted for smoking behaviour)
CSNK2A1	BMI in non-smokers
CSNK2A1	Granulocyte percentage of myeloid white cells
CSNK2A1	Hematocrit
CSNK2A1	Mean corpuscular hemoglobin
CSNK2A1	Red blood cell count
CSNK2A1	Reticulocyte fraction of red cells
CSNK2A1	Red cell distribution width
CSNK2A1	High light scatter reticulocyte count
CSNK2A1	High light scatter reticulocyte percentage of red cells
CSNK2A1	Mean corpuscular volume
CSNK2A1	Reticulocyte count
CSNK2A1	Vitiligo
CSNK2A1	Breast cancer
CSNK2A1	Coronary artery disease
CSNK2A1	Colonoscopy-negative controls vs population controls
CSNK2A1	Nucleus accumbens volume in trauma-exposed individuals
CSNK2A1	Cognitive ability
CSNK2A1	Cognitive ability (multi-trait analysis)
CSNK2A1	Colorectal adenoma (advanced)
CSNK2A1	Urinary tract infection frequency
CSNK2A1	Rheumatic fever
CSNK2A1	Allergic disease (asthma, hay fever or eczema)
CSNK2A1	Anti-saccade response
CSNK2A1	Lobe attachment (rater-scored or self-reported)
CSNK2A1	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)
CSNK2A1	Hepatitis B
CSNK2A1	Tuberculosis
CSNK2A1	Intelligence (multi-trait analysis)
CST1	Blood protein levels
CST2	-
CST3	Plasma cystastin c levels in acute coronary syndrome
CST3	Chronic kidney disease
CST3	Blood protein levels
CST4	-
CST5	-
CST7	-
CST8	-
CST9	-
CST9L	-
CST11	-
CSTF1	-
CSTL1	-
CTCFL	Response to cytadine analogues (cytosine arabinoside)
CTNNBL1	Bone mineral density
CTNNBL1	Visceral adipose tissue adjusted for BMI
CTNNBL1	Cognitive decline rate in late mild cognitive impairment
CTSA	-
CTSZ	Platelet distribution width
CYP24A1	Calcium levels
CYP24A1	Post bronchodilator FEV1
CYP24A1	Anti-saccade response
DBNDD2	-
DDRGK1	Response to hepatitis C treatment
DDRGK1	Migraine
DDRGK1	Night sleep phenotypes
DDRGK1	Macrophage colony stimulating factor levels
DDX27	Intelligence (multi-trait analysis)
DEFB115	-
DEFB116	-
DEFB118	Prudent dietary pattern
DEFB119	-
DEFB121	-
DEFB123	-
DEFB124	-
DEFB125	Neutrophil count
DEFB125	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)
DEFB125	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)
DEFB125	Social communication problems
DEFB125	Cognitive performance
DEFB125	3-hydroxypropylmercapturic acid levels in smokers
DEFB125	3-hydroxy-1-methylpropylmercapturic acid levels in smokers
DEFB125	Posterior cortical atrophy and Alzheimer's disease
DEFB125	Daytime sleep phenotypes
DEFB125	Initial pursuit acceleration
DEFB125	Initial pursuit acceleration in psychotic disorders
DEFB126	Mean platelet volume
DEFB126	Non-alcoholic fatty liver disease histology (other)
DEFB126	Mood disorder in prion disease
DEFB127	Thyroid-associated orbitopathy in graves' disease
DEFB127	Body mass index
DEFB127	TRAIL levels
DEFB128	Homeostasis model assessment of insulin resistance (dietary factor interaction)
DEFB128	Fasting insulin (dietary factor interaction)
DEFB128	C-reactive protein (red blood cell fatty acid level interaction)
DEFB128	Alcoholic chronic pancreatitis
DEFB129	Age of smoking initiation
DEFB129	Obesity-related traits
DEFB129	Vitamin D levels
DEFB129	Gout
DEFB132	Obesity-related traits
DEFB132	3-hydroxy-1-methylpropylmercapturic acid levels in smokers
DEFB132	Colorectal or endometrial cancer
DEFB132	Red blood cell count
DHX35	Itch intensity from mosquito bite adjusted by bite size
DIDO1	Menopause (age at onset)
DLGAP4	Reticulocyte fraction of red cells
DLGAP4	High light scatter reticulocyte count
DLGAP4	Reticulocyte count
DNAJC5	-
DNMT3B	Attention deficit hyperactivity disorder (combined symptoms)
DNMT3B	Inflammatory bowel disease
DNMT3B	Lymphocyte counts
DNMT3B	Lymphocyte percentage of white cells
DNTTIP1	Mean platelet volume
DOK5	Functional MRI
DPM1	-
DSN1	-
DSTN	Presence of antiphospholipid antibodies
DTD1	Obesity-related traits
DTD1	Night sleep phenotypes
DUSP15	-
DYNLRB1	-
DZANK1	Platelet distribution width
DZANK1	Mean platelet volume
E2F1	Asthma
EBF4	-
EDEM2	Protein C levels
EDEM2	Prothrombin time
EDN3	-
EEF1A2	-
EFCAB8	Attention deficit hyperactivity disorder (combined symptoms)
EFCAB8	Type 1 diabetes nephropathy
EIF2S2	-
EIF6	Freckling
ELMO2	-
EMILIN3	-
ENTPD6	Allergic rhinitis
EPB41L1	Height
EPB41L1	Hip circumference
EPPIN	-
ERGIC3	-
ESF1	Intelligence (childhood)
EYA2	Creutzfeldt-Jakob disease
EYA2	Creutzfeldt-Jakob disease (variant)
EYA2	Prion diseases
EYA2	Thiazide-induced adverse metabolic effects in hypertensive patients
EYA2	Waist-to-hip ratio adjusted for body mass index
EYA2	Creutzfeldt-Jakob disease (sporadic)
EYA2	Facial morphology (factor 19)
EYA2	Waist-to-hip ratio adjusted for BMI in active individuals
EYA2	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)
EYA2	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)
EYA2	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)
EYA2	Type 2 diabetes
EYA2	Brain volume in infants (intracranial brain volume)
FAM83C	-
FAM83D	Measles
FAM110A	Obesity-related traits
FAM110A	Response to paliperidone in schizophrenia (Multivariate)
FAM209A	-
FAM209B	Obesity-related traits
FAM210B	-
FAM217B	-
FASTKD5	Eosinophil counts
FERMT1	Metabolite levels  (X-11787)
FERMT1	Survival in colon cancer
FERMT1	Inflammatory bowel disease
FERMT1	Crohn's disease
FERMT1	Monocyte chemoattractant protein-3 levels
FITM2	-
FKBP1A	Intelligence (childhood)
FLRT3	Mood disorder in prion disease
FNDC11	-
FOXA2	-
FOXS1	Mean corpuscular hemoglobin
GATA5	-
GCNT7	-
GDAP1L1	-
GDF5	Height
GDF5	Infant length
GDF5	Waist-to-hip ratio adjusted for body mass index
GDF5	Joint mobility (Beighton score)
GDF5	Hip circumference adjusted for BMI
GDF5	Hip circumference
GDF5	Waist-to-hip ratio adjusted for BMI in active individuals
GDF5	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)
GDF5OS	-
GFRA4	-
GGT7	Coronary artery disease
GGT7	Neuroticism
GGTLC1	-
GHRH	-
GID8	-
GINS1	-
GMEB2	-
GNAS	Event-related brain oscillations
GNAS	Renal function-related traits (BUN)
GNAS	Waist circumference adjusted for body mass index
GNAS	Post bronchodilator FEV1/FVC ratio
GNAS	Sulfasalazine-induced agranulocytosis
GNAS	Platelet distribution width
GNRH2	-
GPCPD1	Occipital cortical area (total cortical area interaction)
GPCPD1	Migraine without aura
GPCPD1	3-hydroxypropylmercapturic acid levels in smokers
GPCPD1	Motion sickness
GPCPD1	Body mass index
GPCPD1	Initial pursuit acceleration
GSS	QRS complex (Cornell)
GTSF1L	-
GZF1	-
HAO1	Hepatocyte growth factor levels
HAO1	QT interval
HCK	Response to hepatitis C treatment
HCK	Fear of minor pain
HELZ2	-
HM13	Eosinophil counts
HNF4A	HDL cholesterol
HNF4A	Type 2 diabetes
HNF4A	Cholesterol, total
HNF4A	C-reactive protein levels
HNF4A	C-reactive protein
HNF4A	Fibrinogen levels
HNF4A	Gut microbiota (bacterial taxa)
HNF4A	C-reactive protein levels or total cholesterol levels (pleiotropy)
HNF4A	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)
HNF4A	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)
HNF4A	Neutrophil percentage of white cells
HNF4A	Myeloid white cell count
HNF4A	Sum neutrophil eosinophil counts
HNF4A	Sum basophil neutrophil counts
HNF4A	Granulocyte count
HNF4A	Hematocrit
HNF4A	Neutrophil count
HRH3	-
HSPA12B	Retinopathy in non-diabetics
HSPA12B	Squamous cell carcinoma
ID1	-
IDH3B	-
IFT52	-
INSM1	-
ISM1	Metabolite levels  (X-11787)
ISM1	Survival in colon cancer
ISM1	Night sleep phenotypes
ITCH	-
ITPA	Ribavirin-induced anemia
ITPA	Chronic hepatitis C infection
ITPA	Inflammatory bowel disease
ITPA	Chronic obstructive pulmonary disease
JAG1	Bone mineral density
JPH2	Clozapine-induced agranulocytosis
JPH2	Glomerular filtration rate (creatinine)
KAT14	-
KCNB1	QT interval
KCNB1	Obesity-related traits
KCNB1	Schizophrenia
KCNB1	White matter hyperintensity burden
KCNB1	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)
KCNB1	Colonoscopy-negative controls vs population controls
KCNB1	Intelligence (multi-trait analysis)
KCNG1	-
KCNK15	-
KCNQ2	Tuberculosis
KCNS1	Bipolar disorder
KCNS1	Mean platelet volume
KIAA1755	Heart rate
KIAA1755	Resting heart rate
KIAA1755	Photic sneeze reflex
KIAA1755	Heart rate variability traits (SDNN)
KIAA1755	Heart rate variability traits (RMSSD)
KIF3B	Monocyte percentage of white cells
KIF3B	Granulocyte percentage of myeloid white cells
KIF16B	Type 1 diabetes
KIF16B	Ileal carcinoids
KIF16B	Response to taxane treatment (docetaxel)
KIF16B	Emphysema imaging phenotypes
KIF16B	Asthma
KIF16B	Post bronchodilator FEV1/FVC ratio
KIZ	Lupus nephritis in systemic lupus erythematosus
KIZ	Height
KIZ	Peanut allergy
L3MBTL1	-
LAMA5	Colorectal cancer
LAMA5	3-hydroxy-1-methylpropylmercapturic acid levels in smokers
LAMA5	Pelvic organ prolapse
LAMP5	-
LBP	Periodontitis (DPAL)
LBP	IgG glycosylation
LIME1	-
LKAAEAR1	-
LPIN3	-
LRRN4	Cough in response to angiotensin-converting enzyme inhibitor drugs
LSM14B	-
LZTS3	Subcortical brain region volumes
LZTS3	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder
LZTS3	Plateletcrit
LZTS3	Platelet count
LZTS3	Putamen volume
MACROD2	Obesity (extreme)
MACROD2	Mean platelet volume
MACROD2	Autism
MACROD2	Non-alcoholic fatty liver disease histology (other)
MACROD2	Eating disorders
MACROD2	Circulating myeloperoxidase levels (serum)
MACROD2	Amyotrophic lateral sclerosis (sporadic)
MACROD2	Obesity-related traits
MACROD2	Presence of antiphospholipid antibodies
MACROD2	Male fertility
MACROD2	White matter lesion progression
MACROD2	Mood disorder in prion disease
MACROD2	3-hydroxy-1-methylpropylmercapturic acid levels in smokers
MACROD2	Thyroid-associated orbitopathy in graves' disease
MACROD2	Percentage gas trapping
MACROD2	Body mass index
MACROD2	Advanced glycation end-product levels
MACROD2	Coronary artery aneurysm in Kawasaki disease
MACROD2	Facial morphology (factor 10, width of nasal floor)
MACROD2	Pediatric bone mineral content (hip)
MACROD2	Pediatric bone mineral density (hip)
MACROD2	TRAIL levels
MACROD2	Pediatric bone mineral density (femoral neck)
MACROD2	Peripheral arterial disease (traffic-related air pollution interaction)
MACROD2	Interleukin-10 levels
MACROD2	Interleukin-12p70 levels
MACROD2	Epstein-Barr virus copy number in lymphoblastoid cell lines
MACROD2	Platelet distribution width
MACROD2	Plateletcrit
MACROD2	Common carotid intima-media thickness in HIV infection
MACROD2	Intelligence (multi-trait analysis)
MAFB	-
MANBAL	-
MAP1LC3A	-
MAPRE1	Attention deficit hyperactivity disorder (combined symptoms)
MAPRE1	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
MAPRE1	Iron status biomarkers (transferrin saturation)
MATN4	Parental longevity (mother's age at death)
MAVS	circulating leptin levels
MAVS	circulating leptin levels adjusted for BMI
MAVS	Schizophrenia
MAVS	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)
MAVS	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease
MC3R	-
MCM8	Menarche and menopause (age at onset)
MCM8	Menopause (age at onset)
MCM8	Response to tocilizumab in rheumatoid arthritis
MCM8	Preeclampsia
MCM8	HIV-1 viral setpoint
MCM8	Schizophrenia
MCM8	Breast cancer
MCM8	Intelligence (multi-trait analysis)
MGME1	-
MKKS	-
MMP9	Mild influenza (H1N1) infection
MMP24	Attention deficit hyperactivity disorder
MMP24OS	Attention deficit hyperactivity disorder
MMP24OS	Ulcerative colitis
MOCS3	-
MRGBP	Subjective well-being
MROH8	Hippocampal atrophy
MROH8	Information processing speed
MRPS26	-
MTG2	-
MTRNR2L3	-
MYBL2	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
MYH7B	Anticoagulant levels
MYH7B	Congenital left-sided heart lesions
MYH7B	Melanoma
MYL9	-
MYLK2	Plateletcrit
MYLK2	Platelet count
MYT1	Colorectal cancer
MYT1	Restless legs syndrome
NAA20	-
NANP	-
NAPB	Facial morphology (factor 15, philtrum width)
NCOA3	Response to treatment for acute lymphoblastic leukemia
NCOA3	Systemic lupus erythematosus
NCOA5	Multiple sclerosis
NCOA6	Glomerular filtration rate (creatinine)
NCOA6	Diisocyanate-induced asthma
NCOA6	Hip circumference adjusted for BMI
NCOA6	Coronary artery disease
NDRG3	-
NDUFAF5	-
NECAB3	-
NELFCD	Response to diuretic therapy in hypertension
NEURL2	-
NFATC2	Self-reported allergy
NFATC2	Amyotrophic lateral sclerosis (sporadic)
NFATC2	Sitting height ratio
NFATC2	Asparaginase hypersensitivity in acute lymphoblastic leukemia
NFATC2	Eosinophil percentage of white cells
NFATC2	Sum eosinophil basophil counts
NFATC2	Allergic disease (asthma, hay fever or eczema)
NFATC2	Lobe attachment (rater-scored or self-reported)
NFATC2	White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)
NFS1	Response to paliperidone in schizophrenia (PANSS score)
NFS1	Response to paliperidone in schizophrenia (Multivariate)
NINL	-
NKAIN4	Cardiovascular disease risk factors
NKX2-2	-
NKX2-4	-
NMTRL-TAA5-1	-
NNAT	-
NOL4L	Age at first birth
NOL4L	Chronic obstructive pulmonary disease
NOL4L	Monocyte count
NOL4L	Immature fraction of reticulocytes
NOL4L	Mean corpuscular hemoglobin
NOL4L	Red blood cell count
NOL4L	Red cell distribution width
NOL4L	High light scatter reticulocyte count
NOL4L	High light scatter reticulocyte percentage of red cells
NOL4L	Mean corpuscular volume
NOP56	-
NPBWR2	Body mass index
NPEPL1	Post bronchodilator FEV1/FVC ratio
NRSN2	Height
NRSN2	Attention deficit hyperactivity disorder
NRSN2	Freckling
NRSN2	Protein C levels
NRSN2	Cholesterol, total
NRSN2	D-dimer levels
NRSN2	Anticoagulant levels
NRSN2	Hemostatic factors and hematological phenotypes
NRSN2	Prothrombin time
NRSN2	Ulcerative colitis
NRSN2	Spine bone size
NRSN2	Migraine - clinic-based
NRSN2	Amyotrophic lateral sclerosis (sporadic)
NRSN2	Infant length
NRSN2	Waist-to-hip ratio adjusted for body mass index
NRSN2	Developmental dysplasia of the hip
NRSN2	Venous thromboembolism
NRSN2	Factor VII levels
NRSN2	Glomerular filtration rate (creatinine)
NRSN2	Triglycerides
NRSN2	Thrombosis
NRSN2	QRS complex (Cornell)
NRSN2	Congenital left-sided heart lesions
NRSN2	Melanoma
NRSN2	Diisocyanate-induced asthma
NRSN2	Response to paliperidone in schizophrenia (PANSS score)
NRSN2	Response to paliperidone in schizophrenia (Multivariate)
NRSN2	Joint mobility (Beighton score)
NRSN2	Hip circumference adjusted for BMI
NRSN2	QRS interval (sulfonylurea treatment interaction)
NRSN2	Hip circumference
NRSN2	Total cholesterol levels
NRSN2	Waist-to-hip ratio adjusted for BMI in active individuals
NRSN2	Blood protein levels
NRSN2	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)
NRSN2	Breast cancer
NRSN2	Coronary artery disease
NRSN2	Lobe attachment (rater-scored or self-reported)
NRSN2	Neuroticism
NSFL1C	Intelligence (multi-trait analysis)
NTSR1	-
NXT1	-
OCSTAMP	-
OGFR	-
OPRL1	LDL peak particle diameter (total fat intake interaction)
OSBPL2	-
OSER1	Granulocyte percentage of myeloid white cells
OTOR	Post-traumatic stress disorder (asjusted for relatedness)
OVOL2	-
OXT	-
PABPC1L	-
PAK5	Obesity-related traits
PAK5	Psoriasis
PAK5	3-hydroxypropylmercapturic acid levels in smokers
PAK5	Growth-regulated protein alpha levels
PANK2	Dialysis-related mortality
PANK2	Alcohol and nicotine co-dependence
PANK2	Response to amphetamines
PANK2	Post bronchodilator FEV1/FVC ratio
PANK2	Huntington's disease progression
PANK2	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis
PANK2	Colonoscopy-negative controls vs population controls
PANK2	Intraocular pressure
PANK2	Itch intensity from mosquito bite adjusted by bite size
PANK2	Measles
PARD6B	-
PAX1	-
PCED1A	-
PCIF1	HDL cholesterol
PCIF1	Triglycerides
PCIF1	Gut microbiota (functional units)
PCIF1	Abdominal aortic aneurysm
PCIF1	Mean corpuscular hemoglobin
PCIF1	Mean corpuscular volume
PCK1	Emphysema imaging phenotypes
PCK1	Prudent dietary pattern
PCMTD2	-
PCNA	Tuberculosis
PCSK2	Biochemical measures
PCSK2	Dialysis-related mortality
PCSK2	Preschool internalizing problems
PCSK2	Obesity-related traits
PCSK2	Gut microbiome composition (summer)
PCSK2	Interleukin-1-beta levels
PDRG1	-
PDYN	Bipolar disorder (body mass index interaction)
PDYN	Bipolar disorder and schizophrenia
PDYN	Obesity-related traits
PDYN	Verbal declarative memory
PDYN	Platelet distribution width
PET117	-
PFDN4	Obesity-related traits
PHACTR3	Menarche and menopause (age at onset)
PHACTR3	Menopause (age at onset)
PHACTR3	Response to tocilizumab in rheumatoid arthritis
PHACTR3	Preeclampsia
PHACTR3	HIV-1 viral setpoint
PHACTR3	Schizophrenia
PHACTR3	Breast cancer
PHACTR3	Intelligence (multi-trait analysis)
PHF20	Migraine - clinic-based
PHF20	Height
PHF20	Response to paliperidone in schizophrenia (PANSS score)
PHF20	Response to paliperidone in schizophrenia (Multivariate)
PHF20	Breast cancer
PI3	-
PIGT	-
PIGU	Melanoma
PIGU	Glomerular filtration rate (creatinine)
PKIG	-
PLAGL2	-
PLCB1	Response to irinotecan in non-small-cell lung cancer
PLCB1	Social communication problems
PLCB1	Cognitive performance
PLCB1	Obesity-related traits
PLCB1	Estradiol plasma levels (breast cancer)
PLCB1	Suicide ideation score in major depressive disorder
PLCB1	Chronic kidney disease
PLCB1	3-hydroxypropylmercapturic acid levels in smokers
PLCB1	3-hydroxy-1-methylpropylmercapturic acid levels in smokers
PLCB1	Daytime sleep phenotypes
PLCB1	Obstructive sleep apnea trait (average respiratory event duration)
PLCB1	Response to paliperidone in schizophrenia (Multivariate)
PLCB1	Diastolic blood pressure
PLCB1	Monocyte count
PLCB1	Lymphocyte counts
PLCB1	Platelet distribution width
PLCB1	White blood cell count
PLCB1	Plateletcrit
PLCB1	Platelet count
PLCB4	Neutrophil count
PLCB4	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)
PLCB4	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)
PLCB4	Posterior cortical atrophy and Alzheimer's disease
PLCB4	Initial pursuit acceleration
PLCB4	Initial pursuit acceleration in psychotic disorders
PLCG1	Cholesterol, total
PLCG1	Height
PLCG1	Age-related disease endophenotypes
PLCG1	Age-related diseases, mortality and associated endophenotypes
PLCG1	Hemoglobin concentration
PLCG1	Coronary artery disease
PLTP	Lipid metabolism phenotypes
PLTP	Pathological gambling
PLTP	Gut microbiota (functional units)
PLTP	HDL cholesterol
PMEPA1	Warfarin maintenance dose
PMEPA1	Verbal declarative memory
POFUT1	Chronic obstructive pulmonary disease
POLR3F	-
PPDPF	-
PPP1R3D	-
PPP1R16B	Schizophrenia
PPP1R16B	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis
PRELID3B	Mean platelet volume
PRELID3B	Platelet distribution width
PREX1	Tonometry
PREX1	Narcolepsy with cataplexy
PREX1	Colorectal cancer
PREX1	Multiple myeloma
PREX1	Diastolic blood pressure
PREX1	Intelligence (multi-trait analysis)
PRND	-
PRNP	Creutzfeldt-Jakob disease
PRNP	Creutzfeldt-Jakob disease (variant)
PRNP	Prion diseases
PRNP	Visceral adipose tissue/subcutaneous adipose tissue ratio
PRNP	Waist-to-hip ratio adjusted for body mass index
PRNP	Creutzfeldt-Jakob disease (sporadic)
PRNP	Post bronchodilator FEV1/FVC ratio
PRNP	Waist-to-hip ratio adjusted for BMI in active individuals
PRNP	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)
PRNP	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)
PRNP	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)
PROCR	Protein C levels
PROCR	D-dimer levels
PROCR	Anticoagulant levels
PROCR	Hemostatic factors and hematological phenotypes
PROCR	Ulcerative colitis
PROCR	Amyotrophic lateral sclerosis (sporadic)
PROCR	Height
PROCR	Venous thromboembolism
PROCR	Factor VII levels
PROCR	Thrombosis
PROCR	Blood protein levels
PROCR	Coronary artery disease
PROKR2	Urinary tract infection frequency
PRPF6	Colorectal cancer
PSMA7	-
PSMF1	Cardiac hypertrophy
PSMF1	Response to citalopram treatment
PSMF1	Relative hand skill
PSMF1	Gut microbiome composition (summer)
PSMF1	Night sleep phenotypes
PSMF1	Angiotensin-converting enzyme inhibitor intolerance
PSMF1	Breast cancer
PSMF1	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes
PTGIS	Schizophrenia
PTK6	Hair shape
PTPN1	Hair morphology
PTPRA	-
PTPRT	Periodontitis (Mean PAL)
PTPRT	Preeclampsia
PTPRT	Fractional exhaled nitric oxide (childhood)
PTPRT	IgG glycosylation
PTPRT	Age-related nuclear cataracts
PTPRT	Urate levels in obese individuals
PTPRT	Sense of smell
PTPRT	Microalbuminuria
PTPRT	Facial morphology (factor 20)
PTPRT	Diisocyanate-induced asthma
PTPRT	Response to paliperidone in schizophrenia (negative Marder score)
PTPRT	Venous thromboembolism adjusted for sickle cell variant rs77121243-T
PTPRT	Paneth cell defects in Crohn's disease
PTPRT	Problematic alcohol use in trauma-exposed individuals
PTPRT	Mononucleosis
PXMP4	Height
PXMP4	Post bronchodilator FEV1/FVC ratio
PYGB	Calcium levels
PYGB	Asymmetrical dimethylarginine levels
PYGB	Peripheral arterial disease (traffic-related air pollution interaction)
R3HDML	Post bronchodilator FEV1/FVC ratio
R3HDML	Colonoscopy-negative controls vs population controls
RAB5IF	-
RAB22A	Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer
RAD21L1	Brain structure
RAD21L1	Response to cytadine analogues (cytosine arabinoside)
RAD21L1	Neuroticism
RAD21L1	Vascular brain injury
RAD21L1	Cognitive decline rate in late mild cognitive impairment
RAD21L1	Night sleep phenotypes
RAD21L1	Tumor necrosis factor alpha levels
RAD21L1	Body mass index (recreational physical activity interaction)
RAD21L1	Itch intensity from mosquito bite adjusted by bite size
RAE1	-
RALGAPA2	IgG glycosylation
RALGAPA2	Post bronchodilator FEV1/FVC ratio
RALGAPB	-
RALY	IFN-related cytopenia
RALY	Breast cancer
RALY	Facial pigmentation
RALY	Squamous cell carcinoma
RALY	Cutaneous squamous cell carcinoma
RALY	Skin sensitivity to sun
RALY	Skin colour saturation
RALY	Basal cell carcinoma
RALY	Cancer
RALY	Cancer (pleiotropy)
RALY	Melanoma
RALY	Vitiligo
RASSF2	Nephrotic syndrome (acquired)
RASSF2	Alcohol consumption
RASSF2	Seasonality
RASSF2	Cerebrospinal fluid AB1-42 levels
RASSF2	Nucleus accumbens volume in trauma-exposed individuals
RBBP8NL	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes
RBBP9	-
RBCK1	Panic disorder
RBCK1	LDL cholesterol
RBCK1	Cholesterol, total
RBCK1	Hippocampal atrophy
RBCK1	Periodontitis (Mean PAL)
RBCK1	Preeclampsia
RBCK1	Fractional exhaled nitric oxide (childhood)
RBCK1	Height
RBCK1	IgG glycosylation
RBCK1	Metabolite levels (HVA-5-HIAA Factor score)
RBCK1	Age-related nuclear cataracts
RBCK1	Urate levels in obese individuals
RBCK1	Gastric adenocarcinoma (histologically verified)
RBCK1	3-hydroxypropylmercapturic acid levels in smokers
RBCK1	Bone mineral accretion in asthma (oral corticosteroid dose interaction)
RBCK1	Dementia and core Alzheimer's disease neuropathologic changes
RBCK1	Verbal declarative memory
RBCK1	Sense of smell
RBCK1	Resting heart rate
RBCK1	Non-response to bupropion and depression
RBCK1	Microalbuminuria
RBCK1	Facial morphology (factor 20)
RBCK1	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)
RBCK1	Diisocyanate-induced asthma
RBCK1	Age-related disease endophenotypes
RBCK1	Response to paliperidone in schizophrenia (negative Marder score)
RBCK1	Age-related diseases, mortality and associated endophenotypes
RBCK1	Venous thromboembolism adjusted for sickle cell variant rs77121243-T
RBCK1	LDL cholesterol levels
RBCK1	Paneth cell defects in Crohn's disease
RBCK1	Total cholesterol levels
RBCK1	Interleukin-18 levels
RBCK1	QT interval (ambient particulate matter interaction)
RBCK1	Immature fraction of reticulocytes
RBCK1	Hemoglobin concentration
RBCK1	Left ventricle wall thickness
RBCK1	Reticulocyte fraction of red cells
RBCK1	High light scatter reticulocyte count
RBCK1	High light scatter reticulocyte percentage of red cells
RBCK1	Reticulocyte count
RBCK1	Coronary artery disease
RBCK1	Hepatitis B
RBCK1	Mononucleosis
RBL1	Height
RBM12	-
RBM38	Reticulocyte fraction of red cells
RBM38	High light scatter reticulocyte count
RBM38	Reticulocyte count
RBM39	-
RBPJL	-
REM1	-
RGS19	-
RIMS4	-
RIN2	Platelet distribution width
RIPOR3	-
RNF24	Cytomegalovirus antibody response
RNF24	Telomere length
RNF24	Estradiol levels
RNF24	Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)
RNF24	Obesity-related traits
RNF24	Schizophrenia
RNF24	Height
RNF24	Cognitive decline rate in late mild cognitive impairment
RNF24	Chin dimples
RNF24	Response to antidepressants in depression
RNF24	Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)
RNF24	Nose size
RNF24	Platelet-derived growth factor BB levels
RNF24	Cleft lip with or without cleft palate
RNF24	Interleukin-4 levels
RNF24	Interleukin-17 levels
RNF24	Immature fraction of reticulocytes
RNF24	Monocyte percentage of white cells
RNF24	Multiple myeloma
RNF24	Granulocyte percentage of myeloid white cells
RNF24	Reticulocyte fraction of red cells
RNF24	High light scatter reticulocyte count
RNF24	High light scatter reticulocyte percentage of red cells
RNF24	Mean corpuscular volume
RNF24	Reticulocyte count
RNF24	Intraocular pressure
RNF24	Idiopathic osteonecrosis of the femoral head
RNF24	Dupuytren's disease
RNF114	Psoriasis
RNF114	Inflammatory skin disease
RNF114	Psoriasis vulgaris
ROMO1	-
RPN2	Hippocampal atrophy
RPN2	Initial pursuit acceleration in psychotic disorders
RPRD1B	Skin pigmentation
RPS21	-
RRBP1	Coronary artery disease
RSPO4	-
RTEL1	Glioma
RTEL1	Glioma (high-grade)
RTEL1	Ulcerative colitis
RTEL1	Dental caries
RTEL1	Glioblastoma
RTEL1	Atopic dermatitis
RTEL1	Non-glioblastoma glioma
RTEL1	Plateletcrit
RTEL1	Telomere length
RTEL1	Allergic disease (asthma, hay fever or eczema)
RTF2	-
SALL4	Nonsyndromic cleft lip with cleft palate
SAMD10	Tonsillectomy
SAMHD1	-
SCAND1	Hip circumference adjusted for BMI
SCP2D1	-
SCRT2	Body mass index
SCRT2	Colorectal cancer
SCRT2	Height
SCRT2	Waist-to-hip ratio adjusted for body mass index
SCRT2	Sitting height ratio
SCRT2	Lung function (FVC)
SCRT2	Waist circumference adjusted for body mass index
SCRT2	Waist circumference adjusted for BMI in active individuals
SCRT2	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)
SCRT2	Waist circumference adjusted for BMI (adjusted for smoking behaviour)
SCRT2	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)
SCRT2	Waist circumference adjusted for BMI in non-smokers
SCRT2	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)
SCRT2	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)
SDC4	-
SDCBP2	Personality traits in bipolar disorder
SDCBP2	Metabolite levels  (X-11787)
SDCBP2	Survival in colon cancer
SDCBP2	Night sleep phenotypes
SDCBP2	Body mass index (alcohol intake interaction)
SEC23B	-
SEL1L2	-
SEMG1	-
SEMG2	-
SERINC3	-
SGK2	-
SIGLEC1	Height
SIGLEC1	Red cell distribution width
SIRPA	Pulmonary function decline
SIRPA	Psychosis (atypical)
SIRPA	Response to citalopram or escitalopram and depression
SIRPA	QT interval (sulfonylurea treatment interaction)
SIRPA	Daytime sleepiness
SIRPA	Basophil percentage of granulocytes
SIRPA	Mean platelet volume
SIRPA	Alcoholic chronic pancreatitis
SIRPB1	Brain connectivity
SIRPB1	Presence of antiphospholipid antibodies
SIRPB1	Thyroid-associated orbitopathy in graves' disease
SIRPB1	Yu-Zhi constitution type in type 2 diabetes
SIRPB1	Body mass index
SIRPB1	TRAIL levels
SIRPB1	Epstein-Barr virus copy number in lymphoblastoid cell lines
SIRPB1	Endometriosis
SIRPB2	Autism
SIRPB2	Circulating myeloperoxidase levels (serum)
SIRPB2	Presence of antiphospholipid antibodies
SIRPB2	Intelligence (multi-trait analysis)
SIRPD	Obesity (extreme)
SIRPD	Male fertility
SIRPD	Coronary artery aneurysm in Kawasaki disease
SIRPD	Platelet distribution width
SIRPD	Mean platelet volume
SIRPD	Plateletcrit
SIRPG	Type 1 diabetes
SIRPG	Ileal carcinoids
SIRPG	Response to taxane treatment (docetaxel)
SIRPG	Emphysema imaging phenotypes
SIRPG	Post bronchodilator FEV1/FVC ratio
SLA2	-
SLC2A4RG	-
SLC2A10	-
SLC4A11	Monocyte percentage of white cells
SLC4A11	Granulocyte percentage of myeloid white cells
SLC9A8	Gut microbiota (beta diversity)
SLC12A5	-
SLC13A3	Chronic kidney disease
SLC13A3	Glomerular filtration rate
SLC13A3	Gout
SLC13A3	Brain volume in infants (white matter)
SLC17A9	-
SLC23A2	Tonometry
SLC23A2	Psoriasis
SLC23A2	Narcolepsy with cataplexy
SLC23A2	QT interval
SLC23A2	Anger
SLC23A2	Systemic lupus erythematosus
SLC23A2	Height
SLC23A2	Obesity-related traits
SLC23A2	Schizophrenia
SLC23A2	Infant length
SLC23A2	Palmitic acid (16:0) levels
SLC23A2	Urate levels in obese individuals
SLC23A2	White matter hyperintensity burden
SLC23A2	Inflammatory skin disease
SLC23A2	Colorectal cancer
SLC23A2	Psoriasis vulgaris
SLC23A2	Gut microbiota (beta diversity)
SLC23A2	Educational attainment (years of education)
SLC23A2	Non-response to citalopram or escitalopram and depression
SLC23A2	Subjective well-being
SLC23A2	Life satisfaction
SLC23A2	Positive affect
SLC23A2	Depression
SLC23A2	Intelligence
SLC23A2	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)
SLC23A2	Multiple myeloma
SLC23A2	Diastolic blood pressure
SLC23A2	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)
SLC23A2	Waist circumference adjusted for BMI in non-smokers
SLC23A2	Waist circumference adjusted for BMI (adjusted for smoking behaviour)
SLC23A2	Coronary artery disease
SLC23A2	Colonoscopy-negative controls vs population controls
SLC23A2	Cognitive ability
SLC23A2	Cognitive ability (multi-trait analysis)
SLC23A2	Hepatitis B
SLC23A2	Intelligence (multi-trait analysis)
SLC24A3	Mean platelet volume
SLC24A3	Aortic root size
SLC24A3	Pulmonary function decline
SLC24A3	Psychosis (atypical)
SLC24A3	Liver enzyme levels (alanine transaminase)
SLC24A3	Matrix metalloproteinase levels
SLC24A3	Age at smoking initiation in chronic obstructive pulmonary disease
SLC24A3	Migraine
SLC24A3	Peripheral arterial disease (traffic-related air pollution interaction)
SLC24A3	QT interval (sulfonylurea treatment interaction)
SLC24A3	Pulse pressure
SLC24A3	White blood cell count (basophil)
SLC24A3	Neutrophil percentage of white cells
SLC24A3	Daytime sleepiness
SLC24A3	Lymphocyte counts
SLC24A3	Lymphocyte percentage of white cells
SLC24A3	Basophil percentage of granulocytes
SLC24A3	Platelet distribution width
SLC24A3	Plateletcrit
SLC24A3	Platelet count
SLC32A1	-
SLC35C2	-
SLC52A3	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)
SLCO4A1	Menopause (age at onset)
SLPI	-
SLX4IP	Body mass index (change over time) in chronic obstructive pulmonary disease
SLX4IP	Fasting blood glucose adjusted for BMI
SMIM26	-
SMOX	Hippocampal atrophy
SMOX	Height
SMOX	Gastric adenocarcinoma (histologically verified)
SMOX	Bone mineral accretion in asthma (oral corticosteroid dose interaction)
SMOX	Dementia and core Alzheimer's disease neuropathologic changes
SMOX	Verbal declarative memory
SMOX	Age-related disease endophenotypes
SMOX	Age-related diseases, mortality and associated endophenotypes
SMOX	Immature fraction of reticulocytes
SMOX	Left ventricle wall thickness
SMOX	Reticulocyte fraction of red cells
SMOX	High light scatter reticulocyte count
SMOX	High light scatter reticulocyte percentage of red cells
SMOX	Reticulocyte count
SMOX	Coronary artery disease
SMOX	Hepatitis B
SNAI1	-
SNAP25	Educational attainment
SNAP25	Diisocyanate-induced asthma
SNAP25	Mononucleosis
SNPH	Sphingolipid levels
SNPH	LDL cholesterol
SNPH	Brain structure
SNPH	Blood metabolite levels
SNPH	Blood metabolite ratios
SNPH	Very long-chain saturated fatty acid levels (fatty acid 20:0)
SNPH	Glycerophospholipid levels
SNPH	Neuroticism
SNPH	Very long-chain saturated fatty acid levels (fatty acid 24:0)
SNPH	Parental extreme longevity (95 years and older)
SNPH	Daytime sleep phenotypes
SNPH	LDL cholesterol levels
SNPH	Body mass index (recreational physical activity interaction)
SNRPB	-
SNRPB2	Plateletcrit
SNTA1	-
SNX5	Mean platelet volume
SNX21	-
SOGA1	-
SOX12	Attention deficit hyperactivity disorder (combined symptoms)
SOX12	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
SOX12	Type 1 diabetes nephropathy
SOX12	Inflammatory bowel disease
SOX12	Type 2 diabetes
SOX12	Ulcerative colitis
SOX12	Subjective well-being
SOX12	Iron status biomarkers (iron levels)
SOX12	Iron status biomarkers (transferrin saturation)
SOX12	Monocyte count
SOX12	White blood cell count (basophil)
SOX12	Basophil percentage of white cells
SOX12	Lymphocyte counts
SOX12	Lymphocyte percentage of white cells
SOX12	Monocyte percentage of white cells
SOX12	Basophil percentage of granulocytes
SOX12	Granulocyte percentage of myeloid white cells
SOX12	Red cell distribution width
SOX12	Birth weight
SOX18	-
SPAG4	-
SPATA2	Psoriasis
SPATA25	-
SPEF1	-
SPINT3	-
SPINT4	-
SPO11	-
SPTLC3	Personality traits in bipolar disorder
SPTLC3	Daytime sleep phenotypes
SPTLC3	Body mass index (alcohol intake interaction)
SRC	Squamous cell carcinoma
SRMS	-
SRSF6	-
SRXN1	Height
SRXN1	QRS complex (Cornell)
SRXN1	Hip circumference adjusted for BMI
SS18L1	-
SSTR4	-
STAU1	Height
STAU1	Cognitive ability
STAU1	Cognitive ability (multi-trait analysis)
STAU1	Intelligence (multi-trait analysis)
STK4	Schizophrenia
STK4	Positive affect
STK35	Lupus nephritis in systemic lupus erythematosus
STK35	Hirschsprung disease
STK35	Body mass index
STK35	Height
STK35	Cannabis dependence symptom count
STK35	Nose morphology
STK35	Facial morphology (factor 7, width of cartilaginous portion of nose)
STK35	Pediatric bone mineral content (radius)
STK35	Sulfasalazine-induced agranulocytosis
STK35	Mean corpuscular hemoglobin
STK35	Peanut allergy
STMN3	-
STX16	-
SULF2	Attention deficit hyperactivity disorder (time to onset)
SULF2	Post bronchodilator FEV1/FVC ratio in COPD
SUN5	-
SYCP2	-
SYNDIG1	-
SYS1	-
TAF4	Smooth-surface caries
TAF4	Body mass index
TASP1	Chin dimples
TASP1	Tonsillectomy
TBC1D20	Rheumatoid arthritis
TBC1D20	HDL cholesterol
TBC1D20	Triglycerides
TBC1D20	Multiple sclerosis
TBC1D20	Psoriasis
TBC1D20	Type 2 diabetes
TBC1D20	Cholesterol, total
TBC1D20	Ulcerative colitis
TBC1D20	C-reactive protein levels
TBC1D20	Lipid metabolism phenotypes
TBC1D20	Kawasaki disease
TBC1D20	Metabolite levels
TBC1D20	Bipolar disorder
TBC1D20	Brain structure
TBC1D20	Conduct disorder (symptom count)
TBC1D20	Response to amphetamines
TBC1D20	C-reactive protein
TBC1D20	Cognitive performance
TBC1D20	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
TBC1D20	IgG glycosylation
TBC1D20	Obesity-related traits
TBC1D20	Current cigarettes per day in chronic obstructive pulmonary disease
TBC1D20	Clozapine-induced agranulocytosis
TBC1D20	Inflammatory bowel disease
TBC1D20	Chronic hepatitis B infection
TBC1D20	Hemoglobin levels
TBC1D20	Crohn's disease
TBC1D20	3-hydroxypropylmercapturic acid levels in smokers
TBC1D20	3-hydroxy-1-methylpropylmercapturic acid levels in smokers
TBC1D20	Pathological gambling
TBC1D20	Schizophrenia
TBC1D20	Pancreatic cancer
TBC1D20	Glomerular filtration rate (creatinine)
TBC1D20	Parental longevity (mother's age at death)
TBC1D20	Coenzyme Q10 levels
TBC1D20	Fibrinogen levels
TBC1D20	Advanced age-related macular degeneration
TBC1D20	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)
TBC1D20	Mild influenza (H1N1) infection
TBC1D20	Gut microbiota (functional units)
TBC1D20	Gut microbiota (bacterial taxa)
TBC1D20	Abdominal aortic aneurysm
TBC1D20	Tonsillectomy
TBC1D20	Late-onset Alzheimer's disease
TBC1D20	C-reactive protein levels or total cholesterol levels (pleiotropy)
TBC1D20	C-reactive protein levels or triglyceride levels (pleiotropy)
TBC1D20	C-reactive protein levels or LDL-cholesterol levels (pleiotropy)
TBC1D20	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)
TBC1D20	Metabolite levels (lipoprotein measures)
TBC1D20	Positive affect
TBC1D20	Post bronchodilator FEV1/FVC ratio in COPD
TBC1D20	Post bronchodilator FEV1/FVC ratio
TBC1D20	Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)
TBC1D20	Facial morphology (factor 21, depth of nasal alae)
TBC1D20	HDL cholesterol levels
TBC1D20	Waist circumference adjusted for BMI (smoking interaction)
TBC1D20	Triglyceride levels
TBC1D20	Monocyte count
TBC1D20	Neutrophil percentage of white cells
TBC1D20	Blood protein levels
TBC1D20	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)
TBC1D20	Lymphocyte percentage of white cells
TBC1D20	Myeloid white cell count
TBC1D20	Monocyte percentage of white cells
TBC1D20	Sum neutrophil eosinophil counts
TBC1D20	Sum basophil neutrophil counts
TBC1D20	Granulocyte count
TBC1D20	Granulocyte percentage of myeloid white cells
TBC1D20	Hematocrit
TBC1D20	Mean corpuscular hemoglobin
TBC1D20	Red blood cell count
TBC1D20	Mean corpuscular volume
TBC1D20	Mean platelet volume
TBC1D20	Neutrophil count
TBC1D20	Coronary artery disease
TBC1D20	Colonoscopy-negative controls vs population controls
TBC1D20	Asthma
TBC1D20	Bacterial meningitis
TBC1D20	Intelligence (multi-trait analysis)
TCEA2	Serum thyroid-stimulating hormone levels
TCEA2	Diastolic blood pressure
TCF15	Non-alcoholic fatty liver disease histology (other)
TCF15	Menopause (age at onset)
TCF15	Survival in colon cancer
TCF15	Abdominal aortic aneurysm
TCF15	Cough in response to angiotensin-converting enzyme inhibitor drugs
TCFL5	Obesity-related traits
TFAP2C	-
TGIF2	-
TGM2	-
TGM3	Liver enzyme levels (alanine transaminase)
TGM3	Basal cell carcinoma
TGM3	PR interval in Tripanosoma cruzi seropositivity
TGM3	Obesity-related traits
TGM3	Venous thromboembolism
TGM3	Inflammatory skin disease
TGM3	Facial morphology (factor 15, philtrum width)
TGM3	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)
TGM3	Tuberculosis
TGM6	Response to TNF antagonist treatment
TGM6	Erectile dysfunction and prostate cancer treatment
TGM6	Alzheimer's disease (cognitive decline)
TGM6	3-hydroxypropylmercapturic acid levels in smokers
TGM6	Body mass index (change over time) in cancer or chronic obstructive pulmonary disease
TGM6	Blood protein levels
THBD	-
TLDC2	-
TM9SF4	Ribavirin-induced anemia
TM9SF4	Chronic hepatitis C infection
TM9SF4	Inflammatory bowel disease
TM9SF4	Chronic obstructive pulmonary disease
TMC2	Systemic lupus erythematosus
TMC2	Obesity-related traits
TMC2	3-hydroxy-1-methylpropylmercapturic acid levels in smokers
TMC2	Parkinson disease and lewy body pathology
TMC2	Colorectal or endometrial cancer
TMC2	Circulating chromogranin peptide levels
TMC2	Red blood cell count
TMEM74B	-
TMEM189	Monocyte percentage of white cells
TMEM189	Granulocyte percentage of myeloid white cells
TMEM230	Bipolar disorder
TMEM230	Molar-incisor hypomineralization
TMEM230	QT interval (drug interaction)
TMEM230	Prostate cancer
TMEM230	Longitudinal change in brain amyloid plaque burden
TMEM230	Breast cancer
TMEM239	White matter integrity
TMX4	-
TNFRSF6B	Atopic dermatitis
TNFRSF6B	Inflammatory bowel disease
TNFRSF6B	Crohn's disease
TNFRSF6B	Ulcerative colitis
TNNC2	-
TOMM34	-
TOP1	LDL cholesterol
TOP1	Cholesterol, total
TOP1	Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)
TOP1	LDL cholesterol levels
TOX2	Conduct disorder (symptom count)
TOX2	IgG glycosylation
TOX2	Post bronchodilator FEV1/FVC ratio in COPD
TOX2	Red blood cell count
TP53INP2	-
TP53RK	-
TP53TG5	-
TPD52L2	-
TPX2	-
TRE-CTC10-1	-
TRI-AAT12-1	-
TRIB3	Bipolar disorder
TRIB3	Bone mineral density
TRIB3	Hippocampal atrophy
TRIB3	Information processing speed
TRIB3	Telomere length
TRIB3	Dialysis-related mortality
TRIB3	Alcohol and nicotine co-dependence
TRIB3	Estradiol levels
TRIB3	Visceral adipose tissue adjusted for BMI
TRIB3	Periodontitis (DPAL)
TRIB3	Asthma
TRIB3	Antibody status in Tripanosoma cruzi seropositivity
TRIB3	Bipolar disorder and schizophrenia
TRIB3	Response to amphetamines
TRIB3	IgG glycosylation
TRIB3	Retinopathy in non-diabetics
TRIB3	Schizophrenia
TRIB3	Airway wall thickness
TRIB3	Survival in colon cancer
TRIB3	circulating leptin levels
TRIB3	circulating leptin levels adjusted for BMI
TRIB3	Heart rate
TRIB3	Height
TRIB3	Post bronchodilator FEV1 in COPD
TRIB3	Cognitive decline rate in late mild cognitive impairment
TRIB3	Resting heart rate
TRIB3	Chin dimples
TRIB3	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)
TRIB3	Squamous cell carcinoma
TRIB3	Post bronchodilator FEV1/FVC ratio
TRIB3	Nose size
TRIB3	Photic sneeze reflex
TRIB3	Platelet-derived growth factor BB levels
TRIB3	Hepcidin levels
TRIB3	Cerebrospinal fluid biomarker levels
TRIB3	Skin pigmentation
TRIB3	Interleukin-4 levels
TRIB3	Interleukin-17 levels
TRIB3	Autism spectrum disorder or schizophrenia
TRIB3	Daytime sleepiness
TRIB3	Huntington's disease progression
TRIB3	Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis
TRIB3	Reticulocyte fraction of red cells
TRIB3	Red cell distribution width
TRIB3	High light scatter reticulocyte count
TRIB3	Mean corpuscular volume
TRIB3	Reticulocyte count
TRIB3	Heart rate variability traits (SDNN)
TRIB3	Heart rate variability traits (RMSSD)
TRIB3	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes
TRIB3	Colonoscopy-negative controls vs population controls
TRIB3	Intraocular pressure
TRIB3	Initial pursuit acceleration in psychotic disorders
TRIB3	Itch intensity from mosquito bite adjusted by bite size
TRIB3	Dupuytren's disease
TRIB3	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease
TRIB3	Measles
TRL-AAG6-1	-
TRMT6	-
TRPC4AP	-
TRQ-CTG17-1	-
TRS-AGA7-1	-
TRV-CAC14-1	-
TSHZ2	Bipolar disorder (body mass index interaction)
TSHZ2	Warfarin maintenance dose
TSHZ2	Coronary artery aneurysm in Kawasaki disease
TSHZ2	Urinary tract infection frequency
TTI1	-
TTLL9	-
TTPAL	-
TUBB1	Platelet distribution width
TUBB1	Mean platelet volume
TUBB1	Platelet count
UBE2C	-
UBE2V1	-
UBOX5	Red blood cell density in sickle cell anemia
UBOX5	Eosinophil counts
UBOX5	Prudent dietary pattern
UCKL1	Metabolite levels  (X-11787)
UQCC1	Height
UQCC1	Spine bone size
UQCC1	Developmental dysplasia of the hip
UQCC1	QRS interval (sulfonylurea treatment interaction)
UQCC1	Waist-to-hip ratio adjusted for body mass index
UQCC1	Waist-to-hip ratio adjusted for BMI in active individuals
UQCC1	Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)
UQCC1	Blood protein levels
UQCC1	Lobe attachment (rater-scored or self-reported)
VAPB	-
VPS16	-
VSTM2L	-
VSX1	-
WFDC2	-
WFDC3	-
WFDC5	-
WFDC6	-
WFDC8	-
WFDC9	-
WFDC10A	-
WFDC10B	-
WFDC11	3-hydroxy-1-methylpropylmercapturic acid levels in smokers
WFDC12	-
WFDC13	-
WISP2	-
XKR7	-
XRN2	Mean corpuscular hemoglobin
YTHDF1	-
YWHAB	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)
ZBP1	Hippocampal atrophy
ZBTB46	Multiple sclerosis
ZBTB46	Obesity-related traits
ZBTB46	Coronary artery disease
ZCCHC3	-
ZFP64	Amyotrophic lateral sclerosis
ZFP64	Facial morphology (factor 23)
ZFP64	Reading disability or specific language impairment (pleiotropy)
ZFP64	Venous thromboembolism adjusted for sickle cell variant rs77121243-T
ZFP64	Testicular germ cell tumor
ZGPAT	Inflammatory bowel disease
ZGPAT	Crohn's disease
ZGPAT	Prostate cancer
ZGPAT	Ulcerative colitis
ZGPAT	Lung function (FEV1)
ZHX3	Cholesterol, total
ZHX3	Height
ZHX3	Resting heart rate
ZHX3	Non-response to bupropion and depression
ZHX3	Total cholesterol levels
ZHX3	Left ventricle wall thickness
ZHX3	Coronary artery disease
ZMYND8	Migraine
ZMYND8	Mean platelet volume
ZNF133	Body mass index
ZNF217	Mean corpuscular hemoglobin
ZNF217	Red blood cell count
ZNF217	Mean corpuscular volume
ZNF217	Allergic disease (asthma, hay fever or eczema)
ZNF334	-
ZNF335	HDL cholesterol
ZNF335	C-reactive protein levels or triglyceride levels (pleiotropy)
ZNF335	HDL cholesterol levels
ZNF335	Coronary artery disease
ZNF335	Intelligence (multi-trait analysis)
ZNF337	-
ZNF341	Height
ZNF343	Allergic rhinitis
ZNF343	Cognitive performance
ZNF343	Glomerular filtration rate in chronic kidney disease
ZNF343	Diisocyanate-induced asthma
ZNF343	Blood protein levels
ZNF343	Conotruncal heart defects (maternal effects)
ZNF512B	-
ZNF831	Hypertension
ZNF831	Blood pressure
ZNF831	Diastolic blood pressure
ZNF831	Systolic blood pressure
ZNF831	Response to antipsychotic therapy (extrapyramidal side effects)
ZNF831	Inflammatory bowel disease
ZNF831	Attention function in attention deficit hyperactive disorder
ZNF831	Ulcerative colitis
ZNF831	Crohn's disease
ZNF831	Lymphocyte counts
ZNF831	Lymphocyte percentage of white cells
ZNF831	Platelet distribution width
ZNF831	Coronary artery disease
ZNFX1	Infant length
ZSWIM1	-
ZSWIM3	3-hydroxypropylmercapturic acid levels in smokers
ZSWIM3	Waist circumference adjusted for BMI (smoking interaction)
ZSWIM3	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)
